Filing Details
- Accession Number:
- 0001562180-20-000347
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-10 19:46:57
- Reporting Period:
- 2020-01-08
- Accepted Time:
- 2020-01-10 19:46:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1262325 | Eric Aguiar | C/O Aisling Capital Llc 888 Seventh Avenue, 12Th Floor New York NY 10106 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-01-09 | 30,000 | $9.29 | 30,000 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-01-09 | 30,000 | $56.39 | 0 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2020-01-08 | 1,250 | $55.91 | 1,250 | No | 4 | M | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-01-09 | 30,000 | $0.00 | 30,000 | $9.29 |
| Common Stock | Restricted Share Unit Award | Acquisiton | 2020-01-08 | 5,000 | $0.00 | 5,000 | $0.00 |
| Common Stock | Restricted Share Unit Award | Disposition | 2020-01-08 | 1,250 | $0.00 | 1,250 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-12-14 | No | 4 | M | Direct | |
| 5,000 | No | 4 | A | Indirect | ||
| 3,750 | No | 4 | M | Indirect |
Footnotes
- The option, representing a right to purchase a total of 30,000 shares was granted on December 15, 2016, vested in four equal installments on December 15, 2016, 2017, 2018 and 2019, subject to the optionholder's continuous service with the Issuer at each vesting date.
- Each restricted share unit represents the contingent right to receive one common share of Biohaven Pharmaceutical Holding Co Ltd.
- The reporting person was granted 5,000 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023 subject to the reporting person's continued service with the issuer at each vesting date.
- Not applicable.
- This restricted stock unit is held by the reporting person's spouse as an employee of the issuer.
Billionaire Hedge Funds
